Pierre-Julien Viailly is an expert in Hematology at Centre Henri Becquerel (France). Pierre-Julien Viailly has authored 93 publications, the most recent in 2026. SLR score: 190 (community average: 125). How the SLR is computed.

LeadR Profile

Pierre-Julien Viailly Centre Henri Becquerel France
190 ScienceLeadR Reputation 190
Network Map

Hematology

Subspecialties: Oncology - Immunology - Neurology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2014 - 2026

Source: PubMed

University of Rouen

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 93

Citations

Citations: 2 052 1st author: 1 Last author: 0 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
PD-L2 is associated with lineage-related transcriptional programs distinct from PD-L1 in primary mediastinal large B-cell lymphoma.
PMID 42386908 — cells, lymphoma, b-cell, lymphoma, leukemia, ligands, b-lymphocytes
Leukemia20260
Integration of circulating tumor DNA profiling in the risk stratification of classical Hodgkin lymphoma in children, adolescents, and young adults.
PMID 42016573 — genes, dna fingerprinting, circulating tumor dna, hodgkin disease, lymphoma, neoplasms, drug therapy, adolescent, diagnosis, dna, mutation, child, chemotherapy
Hemasphere20260
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.
PMID 41979332 — cells, circulating tumor dna, lymphoma, b-cell, lymphoma, neoplasms, predictive value of tests, therapeutics, dna, b-lymphocytes
Blood Adv20260
Combined PET and ctDNA response as a predictor of POD24 for follicular lymphoma after first-line induction treatment.
PMID 40499012 — lymphoma, follicular, lymphoma, predictive value of tests, therapeutics
Blood20250
The clinical impact of EGFR alterations in elderly glioblastoma patients: results from a real-life cohort.
PMID 39549128 — aged, glioblastoma, nervous system neoplasms
J Neurooncol20240

LeadR Networks

Main global connection map